NEW YORK, Nov. 16, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has signed a Sponsored Research Agreement with North Carolina State University ("NC State") to support the continued research and development of HT-KIT, a novel therapeutic for the treatment mast cell cancers.
(PRNewsfoto/Hoth Therapeutics Inc.)
The research will be led by Dr. Glenn Cruse, Assistant Professor, and will focus on characterizing the HT-KIT dose and dosing frequency for treatment of aggressive mastocytosis and mast cell neoplasms using humanized tumor mouse models. In addition, the research will expand therapeutic potential of HT-KIT for the treatment of other cancers where aberrant cKIT signaling contributes to the cancer progression, such as gastrointestinal stromal tumors (GIST) and acute myeloid leukemia (AML).
"We are pleased to announce the continuation of our development of HT-KIT after our earlier announcement of beginning API and drug product manufacturing," said Stefanie Johns, Chief Scientific Officer of Hoth Therapeutics, Inc. "We remain focused on pushing this important cancer therapeutic through to the clinic. The research conducted by Dr. Cruse and NC State will help direct the continued development and clinical planning of this potentially life-saving therapy."
About HT-KITHT-KIT is a new molecular entity (NME) under development for treatment of mast cell derived cancers and anaphylaxis. HT-KIT was developed Dr. Glenn Cruse, Assistant Professor at North Carolina State University. The HT-KIT drug is designed to more specifically target the receptor tyrosine kinase KIT in mast cells, which is required for the proliferation, survival and differentiation of bone marrow-derived hematopoietic stem cells. Mutations in the KIT pathway have been associated with several human cancers, such as gastrointestinal stromal tumors and mast cell-derived cancers (mast cell leukemia and mast cell sarcoma). Based on the initial proof-of-concept success, Hoth intends to initially target mast cell neoplasms for development of HT-KIT, which is a rare, aggressive cancer with poor prognosis. The same target, KIT, also plays a key role in mast cell-mediated anaphylaxis, a serious allergic reaction that is rapid in onset and may cause death. Anaphylaxis typically occurs after exposure to an external allergen that results in an immediate and severe immune response.
Story continues
About Hoth Therapeutics, Inc.Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. Hoth's pipeline development is focused to improve the quality of life for patients suffering from indications including atopic dermatitis, skin toxicities associated with cancer therapy, chronic wounds, psoriasis, asthma, acne, mast-cell derived cancers & anaphylaxis and pneumonia. Hoth has also entered into two different agreements to further the development of two therapeutic prospects to prevent or treat COVID-19. To learn more, please visit https://ir.hoththerapeutics.com/.
Forward-Looking StatementThis press release includes forward-looking statements based upon Hoth's current expectations which may constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 and other federal securities laws, and are subject to substantial risks, uncertainties and assumptions. These statements concern Hoth's business strategies; the timing of regulatory submissions; the ability to obtain and maintain regulatory approval of existing product candidates and any other product candidates we may develop, and the labeling under any approval we may obtain; the timing and costs of clinical trials, the timing and costs of other expenses; market acceptance of our products; the ultimate impact of the current Coronavirus pandemic, or any other health epidemic, on our business, our clinical trials, our research programs, healthcare systems or the global economy as a whole; our intellectual property; our reliance on third party organizations; our competitive position; our industry environment; our anticipated financial and operating results, including anticipated sources of revenues; our assumptions regarding the size of the available market, benefits of our products, product pricing, timing of product launches; management's expectation with respect to future acquisitions; statements regarding our goals, intentions, plans and expectations, including the introduction of new products and markets; and our cash needs and financing plans. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. You should not place reliance on these forward-looking statements, which include words such as "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" or similar terms, variations of such terms or the negative of those terms. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee such outcomes. Hoth may not realize its expectations, and its beliefs may not prove correct. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, market conditions and the factors described in the section entitled "Risk Factors" in Hoth's most recent Annual Report on Form 10-K and Hoth's other filings made with the U. S. Securities and Exchange Commission. All such statements speak only as of the date made. Consequently, forward-looking statements should be regarded solely as Hoth's current plans, estimates, and beliefs. Investors should not place undue reliance on forward-looking statements. Hoth cannot guarantee future results, events, levels of activity, performance or achievements. Hoth does not undertake and specifically declines any obligation to update, republish, or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law.
Investor Contact:LR Advisors LLCEmail: investorrelations@hoththerapeutics.comwww.hoththerapeutics.comPhone: (678) 570-6791
Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-a-sponsored-research-agreement-to-further-develop-novel-mrna-cancer-therapeutic-ht-kit-301425327.html
SOURCE Hoth Therapeutics, Inc.
Continued here:
Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT - Yahoo Finance
- North Carolina Stem Cell Treatment | Stem Cell Treatments [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Carolina Stem Cell Treatment Center | carolina stem ... [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- The Man Who Grew Eyes From Scratch [Last Updated On: August 26th, 2014] [Originally Added On: August 26th, 2014]
- For the first time, researchers isolate adult stem cells ... [Last Updated On: August 26th, 2014] [Originally Added On: August 26th, 2014]
- Charlotte NC Resources - Stem Cells: Get Facts on Uses ... [Last Updated On: September 1st, 2014] [Originally Added On: September 1st, 2014]
- Fayetteville North Carolina Stem Cell Research ... [Last Updated On: September 16th, 2014] [Originally Added On: September 16th, 2014]
- Study Offers Fertility Preservation Option to Young Boys with Cancer [Last Updated On: October 1st, 2014] [Originally Added On: October 1st, 2014]
- Local doctor uses stem cells to heal [Last Updated On: October 29th, 2014] [Originally Added On: October 29th, 2014]
- Committee on Development, Regeneration, and Stem Cell ... [Last Updated On: October 31st, 2014] [Originally Added On: October 31st, 2014]
- New e-Incubator enables real-time imaging of bioengineered tissues in controlled unit [Last Updated On: November 5th, 2014] [Originally Added On: November 5th, 2014]
- Dying child approved for new treatment testing [Last Updated On: January 2nd, 2015] [Originally Added On: January 2nd, 2015]
- Cancer Care Northwest Stem Cell Transplantation [Last Updated On: January 10th, 2015] [Originally Added On: January 10th, 2015]
- COPD Prognosis Stem Cells Canada, COPD Alternative ... [Last Updated On: February 17th, 2015] [Originally Added On: February 17th, 2015]
- Image: Human endothelial cells experiment bound for ISS [Last Updated On: February 26th, 2015] [Originally Added On: February 26th, 2015]
- Core labs | North Carolina Biotech Center [Last Updated On: April 29th, 2015] [Originally Added On: April 29th, 2015]
- Cary North Carolina Stem Cell Research | Cary NC Stem Cell ... [Last Updated On: July 2nd, 2015] [Originally Added On: July 2nd, 2015]
- JCI - Type 2 alveolar cells are stem cells in adult lung [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Stem Cell Research in North Carolina ... Whats Really ... [Last Updated On: August 5th, 2016] [Originally Added On: August 5th, 2016]
- Biotechnology Teacher Resources Online | North Carolina ... [Last Updated On: August 19th, 2016] [Originally Added On: August 19th, 2016]
- Cato - Research Triangle Park, Durham, North Carolina [Last Updated On: August 21st, 2016] [Originally Added On: August 21st, 2016]
- Cary NC Stem Cell Treatment | Cary North Carolina Cancer ... [Last Updated On: November 16th, 2016] [Originally Added On: November 16th, 2016]
- Lung fibrosis? Stem cell therapy holds promise - The Hindu - The Hindu [Last Updated On: August 11th, 2017] [Originally Added On: August 11th, 2017]
- Stem cells may treat lung fibrosis diseases - Futurity: Research News [Last Updated On: August 11th, 2017] [Originally Added On: August 11th, 2017]
- CRISPR Edits Genome of Human Embryos - Alzforum [Last Updated On: August 11th, 2017] [Originally Added On: August 11th, 2017]
- Former basketball star Greg Friel in fight of his life - Fosters - Foster's Daily Democrat [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- Avalon Advisors Has Decreased Its Comcast Cmn Class (CMCSA) Position; Neuralstem (CUR)'s Sentiment Is 0 - High Point Observer [Last Updated On: September 6th, 2017] [Originally Added On: September 6th, 2017]
- Stem Cells in Focus - Blog - Closer Look at Stem Cells [Last Updated On: October 10th, 2017] [Originally Added On: October 10th, 2017]
- Spotlights Archive | The University of North Carolina at ... [Last Updated On: October 15th, 2017] [Originally Added On: October 15th, 2017]
- Charlotte, North Carolina - Stem Cells Transplant Institute [Last Updated On: July 15th, 2018] [Originally Added On: July 15th, 2018]
- Stem Cell Greensboro North Carolina 27455 [Last Updated On: July 15th, 2018] [Originally Added On: July 15th, 2018]
- Bone Marrow Transplant | Durham, Raleigh, North Carolina ... [Last Updated On: July 24th, 2018] [Originally Added On: July 24th, 2018]
- Stem Cell Therapy North Carolina | Regenerative Medicine ... [Last Updated On: October 4th, 2018] [Originally Added On: October 4th, 2018]
- Stem Cell Therapy Latest Research Charlotte, North Carolina [Last Updated On: December 2nd, 2018] [Originally Added On: December 2nd, 2018]
- Alumna to compete for Miss America crown on Sunday - UNCSA [Last Updated On: February 3rd, 2019] [Originally Added On: February 3rd, 2019]
- Stem Cell Chapel Hill North Carolina 27514 [Last Updated On: February 11th, 2019] [Originally Added On: February 11th, 2019]
- Clinical Trial for Autism - cordbloodbank.com [Last Updated On: March 8th, 2019] [Originally Added On: March 8th, 2019]
- Stem Cell Winston Salem North Carolina 27150 [Last Updated On: April 5th, 2019] [Originally Added On: April 5th, 2019]
- Cesca Therapeutics Inc. (KOOL) Can't Be More Safe. Trades Significantly Higher - Invest Tribune [Last Updated On: September 24th, 2019] [Originally Added On: September 24th, 2019]
- Global Synthetic Stem Cells Market to Accumulate Revenues Worth US $42 Million By 2025 - ZMR News Research [Last Updated On: September 24th, 2019] [Originally Added On: September 24th, 2019]
- Heal Yourself: How Exosome Therapy Can Repair Age-Damaged Skin - Market Research Finance [Last Updated On: September 24th, 2019] [Originally Added On: September 24th, 2019]
- Global Synthetic Stem Cells Market Estimated to Reach USD 42 Million By 2025 - Daily Market Updates [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- Reviewing BioCryst Pharmaceuticals Inc. (BCRX)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly [Last Updated On: October 27th, 2019] [Originally Added On: October 27th, 2019]
- Reviewing vTv Therapeutics Inc. (VTVT)'s and Asterias Biotherapeutics Inc. (:)'s results - MS Wkly [Last Updated On: October 27th, 2019] [Originally Added On: October 27th, 2019]
- Clinic pitches unproven treatments to desperate patients, with tips on raising the cash - Seattle Times [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Synthetic Stem Cells Market Is Expecting Revolutionary Growth 2019 with Top Key Players: North Carolina State University (NCSU), Zhengzhou University... [Last Updated On: December 6th, 2019] [Originally Added On: December 6th, 2019]
- Top Florida Medical Spa, Amnion of Florida, Partners With Merakris Therapeutics to Advance Their Non-Surgical Treatment Options - Business Wire [Last Updated On: December 11th, 2019] [Originally Added On: December 11th, 2019]
- The Future of Bioprinting Research Has a New Road Map - 3DPrint.com [Last Updated On: February 14th, 2020] [Originally Added On: February 14th, 2020]
- Searching for the 'big break' that could turn stem cells into a weapon against dementia - Genetic Literacy Project [Last Updated On: February 28th, 2020] [Originally Added On: February 28th, 2020]
- Why Some COVID-19 Cases Are Worse than Others - The Scientist [Last Updated On: February 28th, 2020] [Originally Added On: February 28th, 2020]
- Treatment in clinical trial offers options to woman fighting return of cancer (+ video) - WRAL Tech Wire [Last Updated On: February 28th, 2020] [Originally Added On: February 28th, 2020]
- Balding men could grow hair back in weeks thanks to 'miracle potion' - Daily Star [Last Updated On: May 19th, 2020] [Originally Added On: May 19th, 2020]
- Study finds little evidence to back cord-blood therapy for autism - Spectrum [Last Updated On: June 12th, 2020] [Originally Added On: June 12th, 2020]
- Inside the race to ditch formula and grow breast milk in the lab - Wired.co.uk [Last Updated On: August 23rd, 2020] [Originally Added On: August 23rd, 2020]
- Chancellor Harold L. Martin, on His Plan to Safely Open the Nation's Largest HCBU During COVID-19 - TIME [Last Updated On: August 23rd, 2020] [Originally Added On: August 23rd, 2020]
- Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billion - Reuters [Last Updated On: January 13th, 2021] [Originally Added On: January 13th, 2021]
- Invisible pest causes more than $1 billion in crop losses - The Albany Herald [Last Updated On: January 13th, 2021] [Originally Added On: January 13th, 2021]
- After Bone Marrow Donation Saves 9-Year-Old Boy With Cancer, Boston Mom Fights To Raise Awareness - Here And Now [Last Updated On: February 7th, 2021] [Originally Added On: February 7th, 2021]
- Researchers curb local immune response in horses receiving stem cell injury therapy - Horsetalk [Last Updated On: February 7th, 2021] [Originally Added On: February 7th, 2021]
- Nanodecoy Therapy is an Effective Alternative to Neutralize SARS-CoV-2 Virus - AZoNano [Last Updated On: June 23rd, 2021] [Originally Added On: June 23rd, 2021]
- 'Nanodecoy' Therapy Binds and Neutralizes SARS-CoV-2 Virus - NC State News [Last Updated On: June 23rd, 2021] [Originally Added On: June 23rd, 2021]
- What it means to be the worlds first IVF baby - THE WEEK [Last Updated On: August 31st, 2021] [Originally Added On: August 31st, 2021]
- Cellectis Announces Participation in Five Investor Conferences - Yahoo Finance [Last Updated On: August 31st, 2021] [Originally Added On: August 31st, 2021]
- Study Underway to Evaluate New PD-1/CD3 Antibody in T-cell Lymphoma - Targeted Oncology [Last Updated On: October 28th, 2021] [Originally Added On: October 28th, 2021]
- Cytovia and Cellectis Expand Their TALEN Gene-Edited iNK Partnership to Enable Broader ... - The Bakersfield Californian [Last Updated On: November 22nd, 2021] [Originally Added On: November 22nd, 2021]
- Jasper Therapeutics to Present Updated Data on JSP191 Conditioning in SCID Patients at the 2022 Clinical Immunology Society Annual Meeting - Yahoo... [Last Updated On: April 6th, 2022] [Originally Added On: April 6th, 2022]
- A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked. [Last Updated On: June 4th, 2022] [Originally Added On: June 4th, 2022]
- The Soybean Plant | NC State Extension Publications [Last Updated On: June 4th, 2022] [Originally Added On: June 4th, 2022]
- How psilocybin, the psychedelic in mushrooms, may rewire the brain to ease depression, anxiety - WYFF4 Greenville [Last Updated On: June 13th, 2022] [Originally Added On: June 13th, 2022]
- Pediatric Urologist Dr. Anthony Atala to Receive 2022 Jacobson Innovation Award of the American College of Surgeons for Pioneering Work in... [Last Updated On: June 13th, 2022] [Originally Added On: June 13th, 2022]
- BioRestorative Therapies Annou - GuruFocus.com [Last Updated On: July 3rd, 2022] [Originally Added On: July 3rd, 2022]
- W-S organization working on regenerative therapies for 40 organs, tissues - WRAL TechWire [Last Updated On: July 3rd, 2022] [Originally Added On: July 3rd, 2022]
- Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation... [Last Updated On: July 3rd, 2022] [Originally Added On: July 3rd, 2022]
- How psilocybin, the psychedelic in mushrooms, may rewire the brain to ease depression, anxiety and more - KYMA [Last Updated On: July 19th, 2022] [Originally Added On: July 19th, 2022]
- Vegan Oysters in Shells? This Startup Just Developed a Prototype to Save the Oceans - VegNews [Last Updated On: July 27th, 2022] [Originally Added On: July 27th, 2022]
- Lifting up NC Teachers of the Year and TFA alumni - EdNC [Last Updated On: August 22nd, 2022] [Originally Added On: August 22nd, 2022]
- Grafting and Budding Nursery Crop Plants - North Carolina State University [Last Updated On: October 4th, 2022] [Originally Added On: October 4th, 2022]
- A Look Into the Next Century After 100 Years of Insulin - Cureus [Last Updated On: October 13th, 2022] [Originally Added On: October 13th, 2022]
- Scientists Discover Protein Partners that Could Heal Heart Muscle | Newsroom - UNC Health and UNC School of Medicine [Last Updated On: October 13th, 2022] [Originally Added On: October 13th, 2022]
- Global Synthetic Stem Cells Market Is Expected To Reach Around USD 42 Million By 2025 - openPR [Last Updated On: October 13th, 2022] [Originally Added On: October 13th, 2022]
- Israeli-Based 3D-Printed Lab-Grown Meat Company is Building World's ... [Last Updated On: December 27th, 2022] [Originally Added On: December 27th, 2022]